Prostate Cancer

Targeting All Multiple Magnetic Resonance Imaging Prostate Lesions Does Not Enhance Cancer Detection: Insights from the YAU Prostate Cancer Group. April 22, 2025

Real-world analyses of major adverse cardiovascular events and mortality risk after androgen deprivation therapy initiation in black vs. white prostate cancer patients. April 22, 2025

Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancer. April 22, 2025

How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. April 22, 2025

Current and future directions in theranostics for neuroendocrine prostate cancer. April 22, 2025

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial. April 21, 2025

Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01). April 21, 2025

Patient satisfaction and decision regret in patients undergoing radical prostatectomy: a multicenter analysis. April 21, 2025

Revisiting Skull Metastases of Prostate Cancer at Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography Era: PSMA Uptake Characteristics and Oncological Outcomes. April 21, 2025

BRCA mutations and prostate cancer: should urologist improve daily clinical practice? April 21, 2025

Outcomes of Focal Therapy for Localized Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. April 21, 2025

MXene and prostate cancer: is there promising news? April 18, 2025

Robotic prostatectomy for large-volume prostates in prostate cancer: a retrospective analysis of 50 cases (>100 ml). April 18, 2025

Clinical Context Shapes the Relationship Between Genomic Alterations and Response to AR Inhibitors and Chemotherapy in Metastatic Prostate Cancer. April 18, 2025

PSMA PET/CT scan reveals incidental meningioma in a prostate cancer patient. April 18, 2025

Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials. April 18, 2025

Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis. April 18, 2025

Severe Late Toxicities (Grade 3-5) with 13 Years of Follow-up After Hypofractionated Postprostatectomy Radiotherapy. April 18, 2025

Diagnostic performance of a fully automated AI algorithm for lesion detection and PI-RADS classification in patients with suspected prostate cancer. April 18, 2025

Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0. April 17, 2025

Page 1 of 1473